Q-omics provides the consensus-scored CDY2B profile across patient tissues and cancer cell-line models. CDY2B expression is associated with patient survival in 4 of 34 cancer types, with the highest sampling consensus in LUAD. Additionally, CDY2B RNA expression shows 789 significant gene co-expression associations, with the highest sampling consensus in ESCA. Together, these results highlight LUAD, and ESCA as cancer lineages where CDY2B shows reproducible signals across survival, tumor–normal expression, and patient cross-omics analyses.
Every result is evaluated using two consensus scores. Sampling consensus measures how consistently a finding is reproduced within a cancer lineage across different conditions. Lineage consensus measures how broadly the result is shared across cancer types, distinguishing pan-cancer signals from lineage-specific patterns.